In the subcutaneous xenograft model, we observed that the tumor size in the H3255 RBM10-overexpression xenograft groups was significantly decreased compared with the control groups at the end of the experiment (Figures 9(a) and 9(c)). The gene discussed is RBM10; the disease is neoplasm.